ARTICLE | Company News
Oriel Therapeutics Inc., Novartis deal
April 26, 2010 7:00 AM UTC
Novartis' generics unit, Sandoz International GmbH, acquired Oriel for an undisclosed amount. Oriel develops generics for asthma and chronic obstructive pulmonary disease (COPD). Sandoz gains Oriel's ...